NOR-QD ®

- A progestin-only pill appropriate for nursing mothers

No negative side effects on breast-feeding 1
No adverse effects on health, growth, or development of nursing infants 1

- Appropriate for many patients who cannot tolerate estrogen

- Optimal packaging for ease of patient use

Compact enough to be carried in a purse
Available in familiar 28-day format

- The first progestin-only pill available with 0.35 mg norethindrone 2

SAFETY INFORMATION
Women who use oral contraceptives (OCs) should be strongly advised not to smoke due to the increased risk of cardiovascular side effects. Serious risks reported with the use of OCs include blood clots, stroke, and heart attacks. OCs are contraindicated in women with thrombophlebitis, thromboembolic disorders, breast cancer, hepatic or estrogen-dependent neoplasia, cerebrovascular or coronary artery disease, jaundice, or undiagnosed genital bleeding. OCs do not protect against HIV infection (AIDS) or other sexually transmitted diseases.

Please see full Prescribing Information.
References: 1. Nor-QD full prescribing information. 2. NDTI-IMS America.